OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Expanding the landscape of E3 ligases for targeted protein degradation
Luke T. Kramer, Xiaoyu Zhang
Current Research in Chemical Biology (2022) Vol. 2, pp. 100020-100020
Open Access | Times Cited: 46
Luke T. Kramer, Xiaoyu Zhang
Current Research in Chemical Biology (2022) Vol. 2, pp. 100020-100020
Open Access | Times Cited: 46
Showing 26-50 of 46 citing articles:
Probing the CRL4DCAF12 interactions with MAGEA3 and CCT5 di-Glu C-terminal degrons
Germanna Lima Righetto, Yanting Yin, David M. Duda, et al.
PNAS Nexus (2024) Vol. 3, Iss. 4
Open Access | Times Cited: 1
Germanna Lima Righetto, Yanting Yin, David M. Duda, et al.
PNAS Nexus (2024) Vol. 3, Iss. 4
Open Access | Times Cited: 1
CNS delivery of targeted protein degraders
Prashant Agarwal, Darren L. Reid, Mansoor M. Amiji
Journal of Controlled Release (2024) Vol. 372, pp. 661-673
Open Access | Times Cited: 1
Prashant Agarwal, Darren L. Reid, Mansoor M. Amiji
Journal of Controlled Release (2024) Vol. 372, pp. 661-673
Open Access | Times Cited: 1
Distinct Amino Acid-Based PROTACs Target Oncogenic Kinases for Degradation in Non-Small Cell Lung Cancer (NSCLC)
Jianchao Zhang, Xiao Chen, Congli Chen, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 16, pp. 13666-13680
Closed Access | Times Cited: 1
Jianchao Zhang, Xiao Chen, Congli Chen, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 16, pp. 13666-13680
Closed Access | Times Cited: 1
Synthesis, SAR, and application of JQ1 analogs as PROTACs for cancer therapy
Soumik De, Raghaba Sahu, Shubhendu Palei, et al.
Bioorganic & Medicinal Chemistry (2024) Vol. 112, pp. 117875-117875
Closed Access | Times Cited: 1
Soumik De, Raghaba Sahu, Shubhendu Palei, et al.
Bioorganic & Medicinal Chemistry (2024) Vol. 112, pp. 117875-117875
Closed Access | Times Cited: 1
Mechanistic insights into a heterobifunctional degrader-induced PTPN2/N1 complex
Qi Hao, Manoj K Rathinaswamy, Kelly L. Klinge, et al.
Communications Chemistry (2024) Vol. 7, Iss. 1
Open Access | Times Cited: 1
Qi Hao, Manoj K Rathinaswamy, Kelly L. Klinge, et al.
Communications Chemistry (2024) Vol. 7, Iss. 1
Open Access | Times Cited: 1
PROxAb Shuttle: A non-covalent plug-and-play platform for the rapid generation of tumor-targeting antibody-PROTAC conjugates
Hendrik Schneider, Sebastian Jäger, Doreen Könning, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 4
Hendrik Schneider, Sebastian Jäger, Doreen Könning, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 4
Recruitment of FBXO22 for Targeted Degradation of NSD2
Yan Nie, John R. Tabor, Jianping Li, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 3
Yan Nie, John R. Tabor, Jianping Li, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 3
Charting functional E3 ligase hotspots and resistance mechanisms to small-molecule degraders
Alexander Hanzl, Ryan Casement, Hana Imrichová, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 5
Alexander Hanzl, Ryan Casement, Hana Imrichová, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 5
Exploiting ELIOT for Scaffold-Repurposing Opportunities: TRIM33 a Possible Novel E3 Ligase to Expand the Toolbox for PROTAC Design
Tommaso Palomba, Giusy Tassone, Carmine Vacca, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 22, pp. 14218-14218
Open Access | Times Cited: 5
Tommaso Palomba, Giusy Tassone, Carmine Vacca, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 22, pp. 14218-14218
Open Access | Times Cited: 5
High throughput E3 ligase degron binding assays for novel PROTAC ligand discovery
Robert G. Guenette, Patrick Ryan Potts
Methods in enzymology on CD-ROM/Methods in enzymology (2022), pp. 23-39
Closed Access | Times Cited: 4
Robert G. Guenette, Patrick Ryan Potts
Methods in enzymology on CD-ROM/Methods in enzymology (2022), pp. 23-39
Closed Access | Times Cited: 4
PROTACs: Principles and Mechanisms
Ranbir Singh Saluja, Madhura P. Vaidya, Prashant S. Kharkar
(2024), pp. 21-38
Closed Access
Ranbir Singh Saluja, Madhura P. Vaidya, Prashant S. Kharkar
(2024), pp. 21-38
Closed Access
A Novel Rational PROTACs Design and Validation via AI-Driven Drug Design Approach
Cheng-Li Chou, Chieh-Te Lin, Chien‐Ting Kao, et al.
ACS Omega (2024) Vol. 9, Iss. 37, pp. 38371-38384
Open Access
Cheng-Li Chou, Chieh-Te Lin, Chien‐Ting Kao, et al.
ACS Omega (2024) Vol. 9, Iss. 37, pp. 38371-38384
Open Access
Fragment-based approaches to discover ligands for tumor-specific E3 ligases
Junhyeong Yim, S S Kim, Hyung Ho Lee, et al.
Expert Opinion on Drug Discovery (2024), pp. 1-14
Closed Access
Junhyeong Yim, S S Kim, Hyung Ho Lee, et al.
Expert Opinion on Drug Discovery (2024), pp. 1-14
Closed Access
Protacs in cancer therapy: mechanisms, design, clinical trials, and future directions
Akash Vikal, Rashmi Maurya, Brij Bihari Patel, et al.
Drug Delivery and Translational Research (2024)
Closed Access
Akash Vikal, Rashmi Maurya, Brij Bihari Patel, et al.
Drug Delivery and Translational Research (2024)
Closed Access
Development of PROTACs targeting estrogen receptor: An emerging technique for combating endocrine resistance
Rouming Peng, Xin Liu, Chun‐Chi Chen, et al.
RSC Medicinal Chemistry (2024)
Closed Access
Rouming Peng, Xin Liu, Chun‐Chi Chen, et al.
RSC Medicinal Chemistry (2024)
Closed Access
Pharmacophore-based ML model to filter candidate E3 ligands and predict E3 Ligase binding probabilities
Reagon Karki, Yojana Gadiya, Simran Shetty, et al.
Informatics in Medicine Unlocked (2023) Vol. 44, pp. 101424-101424
Open Access | Times Cited: 1
Reagon Karki, Yojana Gadiya, Simran Shetty, et al.
Informatics in Medicine Unlocked (2023) Vol. 44, pp. 101424-101424
Open Access | Times Cited: 1
Solid‐Phase Synthesis of PROTACs and SNIPERs on Backbone Amide Linked (BAL) Resin
Liam Thomas Hales, Philip E. Thompson
Chemistry - A European Journal (2023) Vol. 29, Iss. 56
Open Access
Liam Thomas Hales, Philip E. Thompson
Chemistry - A European Journal (2023) Vol. 29, Iss. 56
Open Access
Pharmacophoric-based ML model to filter candidate E3 ligands and predict E3 Ligase binding probabilities
Reagon Karki, Yojana Gadiya, Simran Shetty, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Reagon Karki, Yojana Gadiya, Simran Shetty, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Probing the DCAF12 interactions with MAGEA3 and CCT5 C-terminal degrons
Germanna Lima Righetto, Yanting Yin, Victoria Vu, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Germanna Lima Righetto, Yanting Yin, Victoria Vu, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Pooled endogenous protein tagging and recruitment for scalable discovery of effectors for induced proximity therapeutics
Ophir Shalem, Yevgeniy V. Serebrenik, Deepak Mani, et al.
Research Square (Research Square) (2023)
Open Access
Ophir Shalem, Yevgeniy V. Serebrenik, Deepak Mani, et al.
Research Square (Research Square) (2023)
Open Access
Utilizing natural products as new E3 ligase ligands for targeted protein degradation
Yanan GONG, Saiqi Wang, Xiaobing Chen, et al.
Chinese Journal of Natural Medicines (2023) Vol. 21, Iss. 12, pp. 881-883
Closed Access
Yanan GONG, Saiqi Wang, Xiaobing Chen, et al.
Chinese Journal of Natural Medicines (2023) Vol. 21, Iss. 12, pp. 881-883
Closed Access
